Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 751.00
Ask: 751.20
Change: 0.00 (0.00%)
Spread: 0.20 (0.027%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 755.00
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on directors’ remuneration

17 Mar 2023 08:59

RNS Number : 3583T
Standard Chartered PLC
17 March 2023
 

Standard Chartered PLC

17 March 2023

 

Update on directors' remuneration

2020-22 Long-term incentive plan (LTIP) performance outcome

In the 2022 directors' remuneration report (DRR), Standard Chartered PLC (SC) disclosed details of the expected performance outcome for the 2020-22 LTIP awards which began to vest on 15 March 2023. This showed that the threshold Return on Tangible Equity (RoTE) target had not been achieved and that the Remuneration Committee had determined the vesting outcome for the strategic measures at 22 per cent (out of a maximum 33.3 per cent). It was also stated in the DRR that performance against the Total Shareholder Return (TSR) threshold target would be measured in March 2023 and that at the time of the DRR publication, it was not expected to be achieved.

Unlike the RoTE and strategic performance measures, which are assessed on a financial year timeframe, TSR is measured over the LTIP performance period which starts from the date of grant (i.e., 9 March 2020 for the 2020-22 LTIP) and ends on the day before the third anniversary of the grant date. Performance is assessed by calculating the change in TSR over the three-year performance period, based on the average over a month at the start and end of the performance period, and comparing this with SC's disclosed peer group.

The final TSR performance was assessed on 9 March 2023. Following improved share price performance relative to the peer group since the start of 2023, SC ranked above median (i.e., the target for minimum vesting), resulting in an outcome of 14.8 per cent (out of a maximum 33.3 per cent) for TSR, and a total performance outcome of 36.8 per cent, as shown below:

Measure

Weighting

Performance for minimum vesting (25%)

Performance for maximum vesting (100%)

Assessment of achievement

Performance outcome

RoTE in 2022 with CET1 underpin

One-third

8.5%

11.0%

RoTE 8%

 

CET1 passed

0.0%

Relative TSR performance against peer group

One-third

Median

Upper quartile

Above median, below upper quartile

14.8%

Strategic measures

One-third

Details of the performance achieved against the strategic proof points are set out on page 197 of the 2022 annual report.

Improved performance against our strategic priorities

22.0%

Total 2020-22 LTIP performance outcome

36.8%

 

The Remuneration Committee considered carefully the vesting of the 2020-22 LTIP awards, taking account of the factors set out in the DRR and the fact that the TSR measure had been satisfied in part. The Remuneration Committee considers that the values to be delivered continue to remain appropriate, and, for the reasons set out in the DRR, are not a windfall.

Updated single total figure of remuneration for 2022

The projected values disclosed and included in the single total figure of remuneration table for Bill Winters and Andy Halford in the DRR were based on 22 per cent vesting of the 2020-22 LTIP awards, using the three-month average share price to 31 December 2022.

The table below sets out the single total figure of remuneration for 2022 for Bill Winters and Andy Halford, updated with the final performance outcome for the 2020-22 LTIP awards. The single total figures for Bill and Andy represent year-on-year increases of 30 and 27 per cent respectively, reflecting the improved performance achieved for the 2020-22 LTIP awards.

Bill Winters

Andy Halford

£000

2022

2021

2022

2021

Salary

2,418

2,370

1,546

1,515

Pension

245

237

154

152

Benefits

297

165

133

107

Total fixed remuneration

2,960

2,772

1,833

1,774

Annual incentive award

1,499

1,189

945

760

Actual vesting of LTIP award

 

 

Value of vesting awards based on performance

1,540

779

954

498

Value of vesting awards based on share price growth

173

107

Total variable remuneration

3,212

1,968

2,006

1,258

Singe total figure of remuneration

6,172

4,740

3,839

3,032

 

Notes to the single total figure of remuneration table are set out on page 198 of the 2022 annual report.

 

Enquiries to:

Gregg J Powell, Head of Investor Relations +44 (0) 20 7885 5172

Shaun Gamble, Director, Group Media Relations: +44 (0) 20 7885 5934

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKOBQFBKKKND
Date   Source Headline
2nd May 20242:25 pmRNSQ1 2024 Pillar 3 Disclosures
2nd May 20242:06 pmRNSPublication of Supplementary Prospectus
2nd May 20247:00 amRNS1st Quarter Results
1st May 20245:40 pmRNSTransaction in Own Shares
1st May 202412:20 pmRNSNotice of Redemption
1st May 202410:03 amRNSTotal Voting Rights
30th Apr 20245:36 pmRNSTransaction in Own Shares
29th Apr 20245:29 pmRNSTransaction in Own Shares
26th Apr 20245:30 pmRNSTransaction in Own Shares
26th Apr 202410:17 amRNSOverseas Regulatory Announcement
25th Apr 20245:50 pmRNSTransaction in Own Shares
24th Apr 20246:25 pmRNSPublication of a Prospectus
24th Apr 20245:19 pmRNSTransaction in Own Shares
23rd Apr 20245:50 pmRNSTransaction in Own Shares
22nd Apr 20245:40 pmRNSTransaction in Own Shares
19th Apr 20245:35 pmRNSTransaction in Own Shares
18th Apr 20245:35 pmRNSTransaction in Own Shares
17th Apr 20245:35 pmRNSTransaction in Own Shares
16th Apr 20245:35 pmRNSTransaction in Own Shares
15th Apr 20246:05 pmRNSTransaction in Own Shares
12th Apr 20244:54 pmRNSTransaction in Own Shares
12th Apr 20242:05 pmRNSNotice to ADR Holders of 6.409% Preference Shares
11th Apr 20245:45 pmRNSTransaction in Own Shares
10th Apr 20245:30 pmRNSTransaction in Own Shares
9th Apr 20246:05 pmRNSTransaction in Own Shares
8th Apr 20245:16 pmRNSTransaction in Own Shares
8th Apr 202411:32 amRNSNotice of AGM 2024 and Notice of Class Meeting
5th Apr 202410:30 amRNSOverseas Regulatory Announcement
4th Apr 20245:30 pmRNSTransaction in Own Shares
3rd Apr 20245:13 pmRNSTransaction in Own Shares
2nd Apr 20245:45 pmRNSTransaction in Own Shares
2nd Apr 202410:54 amRNSTotal Voting Rights
2nd Apr 20249:30 amRNSChanges to presentation of financial information
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:22 pmRNSNotice to ADR Holders of 6.409% Preference Shares
27th Mar 20245:39 pmRNSTransaction in Own Shares
26th Mar 20245:35 pmRNSTransaction in Own Shares
26th Mar 20244:36 pmRNSDirector/PDMR Shareholding
25th Mar 20245:43 pmRNSTransaction in Own Shares
22nd Mar 20245:35 pmRNSTransaction in Own Shares
21st Mar 20245:55 pmRNSTransaction in Own Shares
20th Mar 20245:30 pmRNSTransaction in Own Shares
20th Mar 20243:08 pmRNSDirector/PDMR Shareholding
19th Mar 20246:05 pmRNSTransaction in Own Shares
19th Mar 20245:45 pmRNSPublication of Final Terms
18th Mar 20245:51 pmRNSTransaction in Own Shares
15th Mar 20245:53 pmRNSTransaction in Own Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
15th Mar 20244:30 pmRNSDirector/PDMR Shareholding
15th Mar 20243:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.